The effects of the heme precursor 5-aminolevulinic acid (ALA) on REV-ERBα activation

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 347-352

  Yamashita, Kohei ^a   Hagiya, Yuichiro ^a   Nakajima, Motowo ^b   Ishizuka, Masahiro ^b   Tanaka, Tohru ^b   Ogura, Shun ichiro ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b SBI Pharmaceuticals Co   (Japan)

Author keywords

5 Aminolevulinic acid; Circadian rhythms; Porphyrin metabolism; REV ERB

Indexed keywords

AMINOLEVULINIC ACID; HEME; HEME OXYGENASE 1; MESSENGER RNA; NUCLEAR RECEPTOR NR1D1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN BMAL1; CELL NUCLEUS RECEPTOR; SODIUM DERIVATIVE; SODIUM FERROUS CITRATE; UNCLASSIFIED DRUG;

ARTICLE; CIRCADIAN RHYTHM; DIPLOIDY; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; CONTROLLED STUDY; DRUG EFFECT; TRANSCRIPTION REGULATION;

EID: 84898815997     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.03.010     Document Type: Article

References (32)

1. Vaze K.M., Sharma V.K. On the adaptive significance of circadian clocks for their owners. Chronobiol. Int. 2013, 30:413-433.
2. Lowrey P.L., Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genomics Hum. Genet. 2004, 5:407-441.
3. Gachon F., Nagoshi E., Brown S.A., Ripperger J., Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004, 113:103-112.
4. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
5. Ripperger J.A., Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat. Genet. 2006, 38:369-374.
6. Siepka S.M., Yoo S.H., Park J., Lee C., Takahashi J.S. Genetics and neurobiology of circadian clocks in mammals. Cold Spring Harbor Symp. Quant. Biol. 2007, 72:251-259.
7. Preitner N., Damiola F., Lopez-Molina L., Zakany J., Duboule D., Albrecht U., et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002, 110:251-260.
8. Yin L., Wu N., Curtin J.C., Qatanani M., Szwergold N.R., Reid R.A., et al. REV-ERBalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 2007, 318:1786-1789.
9. Raghuram S., Stayrook K.R., Huang P., Rogers P.M., Nosie A.K., McClure D.B., et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat. Struct. Mol. Biol. 2007, 14:1207-1213.
10. Ishizuka M., Abe F., Sano Y., Takahashi K., Inoue K., et al. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int. Immunopharmacol. 2011, 11:358-365.
11. Ogura S., Hagiya Y., Tabata K., Kamachi T., Okura I. Improvement of tumor localization of photosensitizers for photodynamic therapy and its application for tumor diagnosis. Curr. Top. Med. Chem. 2012, 12:176-184.
12. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006, 7:392-401.
13. Ogura S., Maruyama K., Hagiya Y., Sugiyama Y., Tsuchiya K., et al. The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. BMC Res. Notes 2011, 4:66.
14. Ishizuka M., Hagiya Y., Mizokami Y., Honda K., Tabata K., et al. Porphyrins in urine after administration of 5-aminolevulinic acid as a potential tumor marker. Photodiagn. Photodyn. Ther. 2011, 8:328-331.
15. Inoue K., Ota U., Ishizuka M., Kawada C., Fukuhara H., et al. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: The potential of photodynamic screening for tumors. Photodiagn. Photodyn. Ther. 2013, 10:484-489.
16. Hagiya Y., Endo Y., Yonemura Y., Takahashi K., Ishizuka M., et al. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro. Photodiagn. Photodyn. Ther. 2012, 9:204-214.
17. Hagiya Y., Fukuhara H., Matsumoto K., Endo Y., Nakajima M., et al. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer. Photodiagn. Photodyn. Ther. 2013, 10:288-295.
18. Ogura S., Kaneko K., Miyajima S., Ohshima K., Yamaguchi K., et al. Proneurotensin/neuromedin N secreted from small cell lung carcinoma cell lines as a potential tumor marker. Proteomics Clin. Appl. 2008, 2:1620-1627.
19. Shende V.R., Neuendorff N., Earnest D.J. Role of miR-142-3p in the post-transcriptional regulation of the clock gene BMAL1 in the mouse SCN. PLoS One 2013, 8(6):e65300.
20. Ivanov A.V., Smirnova O.A., Ivanova O.N., Masalova O.V., Kochetkov S.N., et al. Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS One 2011, 6(9):e24957.
21. Vieira E., Marroquí L., Figueroa A.L.C., Merino B., Fernandez-Ruiz R., et al. Involvement of the clock gene REV-ERB alpha in the regulation of glucagon secretion in pancreatic alpha-cells. PLoS One 2013, 8(7):e69939.
22. Balsalobre A., Damiola F., Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998, 93:929-937.
23. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., et al. Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science 1994, 264:719-725.
24. Marcheva B., Ramsey K.M., Buhr E.D., Kobayashi Y., Su H., et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010, 466:627-631.
25. Yang S., Van Dongen H.P., Wang K., Berrettini W., Bućan M. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol. Psychiatry 2009, 14:143-155.
26. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer Inst. 2001, 93:1563-1568.
27. Straif K., Baan R., Grosse Y., Secretan B., El Ghissassi F., et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007, 8:1065-1066.
28. Kaasik K., Lee C.C. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 2004, 430:467-471.
29. Kumar S., Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 2005, 157:175-188.
30. Grant D., Yin L., Collins J.L., Parks D.J., Orband-Miller L.A., et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor REV-ERBα. ACS Chem. Biol. 2010, 5:925-932.
31. Kojetin D., Wang Y., Kamenecka T.M., Burris T.P. Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem. Biol. 2011, 6:131-134.
32. Solt L.A., Wang Y., Banerjee S., Hughes T., Kojetin D.J., et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012, 485:62-68.